Estimates Revisions Spero Therapeutics, Inc. Börse Stuttgart
Stocks
2HA
US84833T1034
Biotechnology & Medical Research
|
Market Closed -
Börse Stuttgart
20:55:14 09/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 1.056 EUR | +5.28% |
|
+0.67% | -44.60% |
| 08-12 | Spero Therapeutics, Inc., Q2 2026 Earnings Call, Aug 12, 2026 | |
| 08-12 | Spero Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Data source:
Spero Therapeutics, Inc.(SPRO)
EBIT - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
- Stock Market
- Stocks
- SPRO Stock
- 2HA Stock
- Consensus Spero Therapeutics, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
